Business
Raytheon Wins $745 Million MDA Contract for SM-3 IIA Interceptors
Raytheon, an RTX business, won a $745 million Missile Defense Agency contract for SM-3 IIA interceptor production and sustainment through 2031.
Biotech
Moderna Wins EU Contract to Supply RSV Vaccine to Six Countries
Moderna won a European Commission framework contract for up to 24 million mRESVIA RSV vaccine doses over four years across six countries.
-
Eli Lilly to Buy AtaiBeckley in Deal Worth up to $3.8 Billion
Eli Lilly agreed to buy AtaiBeckley for $2.8 billion upfront plus up to $1.0 billion in milestones, adding psychedelic depression assets to its pipeline.
-
Novartis to Buy UK's Myricx Bio in Deal Worth Up to $1.5 Billion
Novartis will buy UK biotech Myricx Bio for $1.1 billion upfront plus up to $400 million in milestones to expand its targeted cancer therapy pipeline.
-
United Therapeutics to Buy Thymmune for Up to $300 Million
United Therapeutics will acquire Thymmune for $140 million upfront plus up to $160 million in milestones, adding a preclinical thymic cell therapy platform.
Editor's Pick
Anthropic and OpenAI Test the Rules for Valuing AI Revenue
AI · · 6 min read
Combined private-market valuations above $1 trillion rest on revenue growth that is real but far smaller, forcing investors to separate consumption run rate from durable recurring revenue.
Read the full story